A Trial of SHR-1316 Maintenance Therapy for Limited Stage Small Cell Lung Cancer
NCT04647357
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Limited-stage Small Cell Lung Cancer, LS-SCLC
Interventions
DRUG:
SHR-1316
Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology